- Research proposal
- OPEN ACCESS
-
Evaluating the effect and mechanism of Yiqi Huayu Jiedu decoction combined with FLOT regimen neoadjuvant chemotherapy for the patients with locally advanced gastric cancer: protocol for a prospective, double-arm, randomized controlled clinical trial
-
Kun Zou1,#,
-
Pei-Chan Zhang1,2,#,
-
Chun-Yang Luo1,2,#,
-
Rui Wang1,2,
-
Shuo Xu3,
-
Chun-Jie Xiang4,
-
Xiang-Kun Huan1,
-
Wen-Chao Yao1,
-
Xiu-Yuan Li5,
-
Jun-Feng Zhang3 and
-
Shen-Lin Liu6,*
Author information
Department of Surgical Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China
No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China
School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
School of Medicine, Southeast University, Nanjing 210009, China
Gastroenterology Department, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China
Department of Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China
Correspondence to: Shen-Lin Liu, Department of Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China. E-mail:
zfwu990214@163.com
Abstract
Background
Neoadjuvant chemotherapy plays a vital role in the treatment of advanced gastric cancer (GC), however, optimizing its effectiveness remains an important research focus. Traditional Chinese medicine (TCM), a promising adjunctive therapy, has shown enhanced clinical outcomes when combined with postoperative adjuvant chemotherapy. Therefore, this study is designed to evaluate the clinical efficacy of Yiqi Huayu Jiedu decoction combined with neoadjuvant chemotherapy FLOT in the treatment of advanced GC.
Methods
This study is a prospective, double-arm, randomized controlled trial. It involves a total of 260 patients diagnosed with advanced GC, who will be randomly assigned to two groups - a TCM treatment group and a control group, each comprising 130 patients. All patients will receive standard FLOT chemotherapy, and patients in the TCM treatment group will additionally receive TCM treatment with Yiqi Huayu Jiedu decoction. After four cycles of chemotherapy, GC D2 radical surgery will be performed. The primary objective is to evaluate the postoperative pathological response rate of the tumor. The secondary objectives include evaluating the perioperative nutritional status, the efficacy of TCM syndrome, and adverse events associated with both chemotherapy and surgery.
Discussion
Currently, no trials have investigated the impact of TCM in combination with neoadjuvant chemotherapy on the preoperative treatment in patients with advanced GC. Accordingly, it is imperative to conduct this prospective study to evaluate the clinical efficacy and safety of this regimen, meanwhile providing high-level clinical evidence for TCM combined with neoadjuvant chemotherapy and introducing an innovative regimen for preoperative comprehensive treatment of GC.
Keywords
Yiqi Huayu Jiedu decoction,
FLOT chemotherapy,
Neoadjuvant chemotherapy,
Gastric cancer
|
Copyright © 2025 Authors.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
About this Article
Cite this article
|
Zou K, Zhang PC, Luo CY, Wang R, Xu S, Xiang CJ, et al. Evaluating the effect and mechanism of Yiqi Huayu Jiedu decoction combined with FLOT regimen neoadjuvant chemotherapy for the patients with locally advanced gastric cancer: protocol for a prospective, double-arm, randomized controlled clinical trial. Gastroenterol & Hepatol Res. 2024;6(1):3. doi: 10.53388/ghr2024003.
|
| Copied to clipboard
|
Copy
Export to RIS
Export to EndNote
|
|
Citation copied!
|
Article History
| Received |
Revised |
Accepted |
Published |
|
|
|
|
March 27, 2024
|
DOI
http://dx.doi.org/10.53388/ghr2024003
-
Gastroenterology & Hepatology Research
-
-
eISSN 2703-173X